Company Overview and News


Add PGNX
to your dashboard

Headline News

Progenic's Azedra SPA: 2 Dose Monte

2017-11-09 seekingalpha
Analyzing and interpreting the results of Progenics's Azedra trial has become a hotly debated topic on Seeking Alpha. (12-1)

Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst

2017-11-06 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (692-4)

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q3 2017 Results - Earnings Call Transcript

2017-11-02 seekingalpha
Good day, ladies and gentlemen, and welcome to the Progenics Pharmaceuticals Third Quarter 2017 Results Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call may be recorded. (31-0)

Editors' Picks Daily: Halloween - What Scares You In Today's Market?

2017-11-01 seekingalpha
Articles get tagged with an Editors’ Pick award when they appeal to a broad audience and demonstrate convincing analysis and a clear actionable takeaway. (40-0)

Biotech Forum Daily Digest: Possible Buyout Scenarios For Neos Therapeutics

2017-10-31 seekingalpha
We had one decent sized acquisition in the market to open the trading week yesterday and Adamas Pharmaceuticals rallies on an analyst's upbeat call. (294-4)

Biotech Forum Daily Digest: Spotlighting Ignyta's Big Recent Rally

2017-10-19 seekingalpha
While the main biotech indices are holding up well despite minor losses, sentiment on some smaller 'Tier 3' concerns seems to be noticeably weakening. (311-1)

Antibody Drug Conjugates Market Grow at 21.82% CAGR By 2022, Analysis by Adcetris, Kadcyla and Pipeline Drugs

2017-09-28 prnewswire
"Global Antibody Drug Conjugates (ADC) Market Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", has covered and analyzed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. Antibody Drug Conjugates Market (ADC) is projected to display a robust growth represented by a CAGR of 21. (126-0)

Conference Roundup: 3 Biotechs Hit The Investor Circuit

2017-09-28 seekingalpha
Three companies I cover on Seeking Alpha, Novavax, Progenics, and Dynavax, presented at healthcare investor conferences this week. (158-9)

Progenics Pharmaceuticals Is A Value Play

2017-09-21 seekingalpha
Progenics operates in the oncology segment. Its current major product is Relistor which is marketed and commercialized through Valeant Pharmaceuticals. (13-0)

Pay Attention To Progenics Pharmaceuticals - Bret Jensen's Idea Of The Month

2017-09-17 seekingalpha
We have extended our partnership with Cheddar TV to produce a Seeking Alpha 'Idea of the Month' segment. (1-1)

3 Biotech Stocks I'd Buy Right Now

2017-09-15 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. (3-5)

Progenics: Dynavax 2.0?

2017-08-15 seekingalpha
Progenics presents an opportunity much like Dynavax in Q1 2017: Risk-averse investors can play the short-term overreaction, while risk-tolerant investors should profit by holding through the forthcoming events. (0-1)

3 Beaten-Up Biotech Stocks: Are They Bargains?

2017-08-14 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. (0-1)

CUSIP: 743187106